title: Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
abstract: BACKGROUND
  The present study aimed to evaluate etiology-based differences in the risk of waiting list mortality, and to compare the current Japanese transplant allocation system with the Child-Turcotte-Pugh (CTP) and the Model for End-Stage Liver Disease (MELD) scoring systems with regard to the risk of waiting list mortality in patients with primary biliary cirrhosis (PBC).
  
  
  METHODS
  Using data derived from all adult candidates for deceased donor liver transplantation in Japan from 1997 to 2011, we assessed factors associated with waiting list mortality by the Cox proportional hazards model. The waiting list mortality risk of PBC patients was further estimated with adjustment for each scoring system.
  
  
  RESULTS
  Of the 1056 patients meeting the inclusion criteria, 743 were not on the list at the end of study period; waiting list mortality was 58.1 % in this group. In multivariate analysis, increasing age and PBC were significantly associated with an increased risk of waiting list mortality. In comparison with patients with hepatitis C virus (HCV) infection, PBC patients were at 79 % increased risk and had a shorter median survival time by approximately 8 months. The relative hazard of PBC patients was statistically significant with adjustment for CTP score and medical point score, which was the priority for ranking candidates in the Japanese allocation system. However, it lost significance with adjustment for MELD score. Stratification by MELD score indicated a comparable waiting list survival time between patients with PBC and HCV.
  
  
  CONCLUSIONS
  PBC patients are at high risk of waiting list mortality in the current allocation system. MELD-based allocation could reduce this risk.
authors.affiliation: Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, 1129 Nagaoka Izunokuni-shi, Shizuoka, 410-2295, Japan, genda@rice.ocn.ne.jp.
authors.forename: Takuya
authors.initials: T
authors.lastname: Genda
authors.forename: Takafumi
authors.initials: T
authors.lastname: Ichida
authors.forename: Shotaro
authors.initials: S
authors.lastname: Sakisaka
authors.forename: Michio
authors.initials: M
authors.lastname: Sata
authors.forename: Eiji
authors.initials: E
authors.lastname: Tanaka
authors.forename: Ayano
authors.initials: A
authors.lastname: Inui
authors.forename: Hiroto
authors.initials: H
authors.lastname: Egawa
authors.forename: Kouji
authors.initials: K
authors.lastname: Umeshita
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Furukawa
authors.forename: Seiji
authors.initials: S
authors.lastname: Kawasaki
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Inomata
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D058625:End Stage Liver Disease / Q000209:etiology / Q000401:mortality* / Q000601:surgery; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008103:Liver Cirrhosis / Q000401:mortality / Q000601:surgery / Q000821:virology; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000401:mortality* / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012720:Severity of Illness Index; D015996:Survival Rate; D009927:Tissue and Organ Procurement; D014850:Waiting Lists / Q000401:mortality*; D055815:Young Adult